FDA Announces Effort to Promote Best Practices Across Advisory Committee
As part of the Food and Drug Administration's broader effort to modernize approaches to managing the new drug review process, the agency's Center for Drug Evaluation and Research (CDER) is launching an internal assessment of its Advisory Committee Meeting system in order to establish best practices surrounding this important process.